Articles published by ReCode Therapeutics
![](https://mms.businesswire.com/media/20240627289896/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20240613760228/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20240513239507/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20240501402596/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20240221731121/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20240220712796/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Participate in February Conferences
February 20, 2024
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20240215392146/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20240103922222/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20231110718436/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Participate in November Conferences
November 10, 2023
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230919336968/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics Announces Closing of Extension to Series B Financing
September 19, 2023
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230907573518/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Present at September Investor Conferences
September 07, 2023
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230710754844/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230602005002/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230417005352/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230327005051/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230321005002/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230315005163/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230201005276/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230110005385/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230109005232/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20230103005189/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221201005398/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics Appoints Trisha Millican to Board of Directors
December 01, 2022
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221122005008/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022
November 22, 2022
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221114005012/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics Establishes Scientific Advisory Board
November 14, 2022
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221102005001/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220929005748/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Participate in Upcoming October Investor Conferences
September 29, 2022
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220922005033/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit
September 22, 2022
From ReCode Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20220912005325/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
![](https://mms.businesswire.com/media/20220906005004/en/1498350/5/ReCode_Logo_Primary_Web%402000px.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.